Through the Eyes of Patients: Understanding Treatment Burden of Intravitreal Anti-VEGF Injections for nAMD Patients in Norway
Gudrun Reitan,1 Inga Britt Kjellevold Haugen,2 Kristoffer Andersen,3 Ragnheidur Bragadottir,4,5 Christian Bindesbøll3 1Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway; 2Department of Research, The Norwegian Association of the Blind and Partiall...
Main Authors: | Reitan G, Kjellevold Haugen IB, Andersen K, Bragadottir R, Bindesbøll C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-05-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/through-the-eyes-of-patients-understanding-treatment-burden-of-intravi-peer-reviewed-fulltext-article-OPTH |
Similar Items
-
Providing a Safe and Effective Intravitreal Treatment Service: Strategies for Service Delivery
by: Amoaku W, et al.
Published: (2020-05-01) -
Findings of uncertain significance by optical coherence tomography (OCT) as prognostic factors in neovascular age-related macular degeneration (nAMD) treated with ranibizumab
by: Ricardo Hayashi-Mercado, et al.
Published: (2022-04-01) -
Baseline characteristics and treatment response predictive of nAMD outcomes with ranibizumab therapy in treatment-naive patients: the RACER subgroup analysis
by: Ching-Yao Tsai, et al.
Published: (2023-01-01) -
New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)
by: Prem Patel, et al.
Published: (2021-05-01) -
Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
by: Nicola Ferrante, et al.
Published: (2022-04-01)